GB1493006A - Cyclic-substituted derivatives of 1-amino-2-propanol - Google Patents

Cyclic-substituted derivatives of 1-amino-2-propanol

Info

Publication number
GB1493006A
GB1493006A GB18491/75A GB1849175A GB1493006A GB 1493006 A GB1493006 A GB 1493006A GB 18491/75 A GB18491/75 A GB 18491/75A GB 1849175 A GB1849175 A GB 1849175A GB 1493006 A GB1493006 A GB 1493006A
Authority
GB
United Kingdom
Prior art keywords
propanol
prepared
methyl
reaction
pyridyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB18491/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1493006A publication Critical patent/GB1493006A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB18491/75A 1974-05-14 1975-05-02 Cyclic-substituted derivatives of 1-amino-2-propanol Expired GB1493006A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH658274A CH591448A5 (enExample) 1974-05-14 1974-05-14
CH156177A CH592625A5 (enExample) 1974-05-14 1974-05-14
CH661874A CH594626A5 (enExample) 1974-05-14 1974-05-14

Publications (1)

Publication Number Publication Date
GB1493006A true GB1493006A (en) 1977-11-23

Family

ID=27173079

Family Applications (1)

Application Number Title Priority Date Filing Date
GB18491/75A Expired GB1493006A (en) 1974-05-14 1975-05-02 Cyclic-substituted derivatives of 1-amino-2-propanol

Country Status (12)

Country Link
US (1) US4027027A (enExample)
JP (1) JPS50154213A (enExample)
AT (1) AT345288B (enExample)
AU (1) AU8104575A (enExample)
BE (1) BE828989A (enExample)
CA (1) CA1067077A (enExample)
CH (3) CH591448A5 (enExample)
DE (1) DE2520910A1 (enExample)
FR (1) FR2270863B1 (enExample)
GB (1) GB1493006A (enExample)
NL (1) NL7504864A (enExample)
SE (1) SE7504375L (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006614A3 (en) * 1978-06-27 1980-01-23 Merck & Co. Inc. Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
EP0007448A1 (en) * 1978-06-27 1980-02-06 Merck & Co. Inc. Pyridyloxypropanolamines and esters thereof, process for preparing the same and pharmaceutical compositions containing them
EP0009075A1 (en) * 1978-06-27 1980-04-02 Merck & Co. Inc. Pyridyloxy-propanol amines and esters thereof, process for preparing the same and pharmaceutical compositions containing them
US4206117A (en) 1977-03-17 1980-06-03 Basf Aktiengesellschaft Pyridinyl aminoalkyl ethers
US4235919A (en) 1977-07-21 1980-11-25 Sandoz Ltd. 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
US4381398A (en) 1979-03-20 1983-04-26 Kyowa Hakko Kogyo Co., Ltd. Amino-alcohol derivatives

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193995A (en) * 1972-05-05 1980-03-18 Merck Sharp & Dohme (I.A.) Corp. 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazine compounds and compositions
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4853383A (en) * 1975-03-03 1989-08-01 Merck & Co., Inc. β-blocking substituted imidazoles
US4440774A (en) * 1975-03-03 1984-04-03 Merck & Co., Inc. 3-Amino-2-hydroxypropoxyaryl imidazole derivatives
US4263323A (en) * 1976-10-07 1981-04-21 Aktiebolaget Hassle β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
US4264599A (en) * 1977-07-08 1981-04-28 Ciba-Geigy Corporation Piperidino-propanols
US4263325A (en) * 1977-10-05 1981-04-21 Aktiebolaget Hassle β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
IT1165040B (it) * 1979-04-23 1987-04-22 Isf Spa Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
US4599333A (en) * 1982-06-14 1986-07-08 Teikoku Hormone Mfg. Co., Ltd. Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
US4920134A (en) * 1987-08-07 1990-04-24 Takeda Chemical Industries, Ltd. 2-O-pyrimidinyl glycerol derivatives
US5221674A (en) * 1989-06-19 1993-06-22 Teikoku Hormone Mfg. Co., Ltd. Pyridazinone derivatives
NZ234087A (en) * 1989-06-19 1991-08-27 Teikoku Hormone Mfg Co Ltd 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
CA2314458A1 (en) * 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU65414A1 (enExample) * 1972-05-24 1973-12-04

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206117A (en) 1977-03-17 1980-06-03 Basf Aktiengesellschaft Pyridinyl aminoalkyl ethers
US4235919A (en) 1977-07-21 1980-11-25 Sandoz Ltd. 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
EP0006614A3 (en) * 1978-06-27 1980-01-23 Merck & Co. Inc. Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
EP0007448A1 (en) * 1978-06-27 1980-02-06 Merck & Co. Inc. Pyridyloxypropanolamines and esters thereof, process for preparing the same and pharmaceutical compositions containing them
EP0009075A1 (en) * 1978-06-27 1980-04-02 Merck & Co. Inc. Pyridyloxy-propanol amines and esters thereof, process for preparing the same and pharmaceutical compositions containing them
US4381398A (en) 1979-03-20 1983-04-26 Kyowa Hakko Kogyo Co., Ltd. Amino-alcohol derivatives
US4450115A (en) * 1979-03-20 1984-05-22 Kyowa Hakko Kogyo Co., Ltd. Amino-alcohol derivatives

Also Published As

Publication number Publication date
FR2270863A1 (enExample) 1975-12-12
CH592625A5 (enExample) 1977-10-31
BE828989A (fr) 1975-11-13
ATA364675A (de) 1978-01-15
CH594626A5 (enExample) 1978-01-13
US4027027A (en) 1977-05-31
FR2270863B1 (enExample) 1979-05-18
JPS50154213A (enExample) 1975-12-12
NL7504864A (nl) 1975-11-18
AU8104575A (en) 1976-11-18
CA1067077A (en) 1979-11-27
SE7504375L (sv) 1975-11-17
CH591448A5 (enExample) 1977-09-15
DE2520910A1 (de) 1975-12-04
AT345288B (de) 1978-09-11

Similar Documents

Publication Publication Date Title
CA1067077A (en) Process for the manufacture of cyclic-substituted derivatives of 1-amino-2-propanol
US4460590A (en) Diglycidyl substituted heterocyclic compounds
FR2336935A1 (fr) Nouvelles pyrimidones, leur procede de preparation et leur application
EP0921122B1 (en) Epoxysuccinamide derivatives or salts thereof
KR830010072A (ko) 아미디노 피페리딘 유도체의 제조방법
GB1419080A (en) Chemical compounds having juvenile hormone activity
SU496724A3 (ru) Способ получени аминоспиртов
KR890006627A (ko) 천식치료제인 치환된 테트랄린, 크로만 및 관련화합물
EP0001699A2 (en) Derivatives of furyl compounds, their preparation and pharmaceutical compositions containing them
US3959283A (en) Amino-derivatives of 1,4-benzodioxan
US4550111A (en) Alkanolamine derivatives
GB1423073A (en) Amines and processes for their manufacture
KR840001951B1 (ko) 치환된 질소함유-헤테로사이클릭화합물의 제조방법
CA1197847A (en) N-substituted polyglycidyl urazole compounds, processes for their production and pharmaceutical preparations
LaMattina et al. The reaction of 5-acetyl-2-aminooxazole with amines: an approach to 1H-5-acetyl-2-aminoimidazoles
US3211741A (en) N-(pyridyl alkylene)-2-propynylamines
DE3314196A1 (de) Heterocyclylaether
CS273172B2 (en) Method of dihydropyridine derivatives production
Maruyama et al. Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists
US5371088A (en) 1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof
CA1141392A (en) Process for making new derivatives of dimers of isoeugenol
ES2121071T3 (es) Compuestos de oxazolidina y su empleo como medicamentos.
NZ512500A (en) Process for preparing a 2-halo-3-nitro-4-aminopyridine compound
CH590235A5 (en) Di-aryl substd.-1-amino-2-propanols - as beta receptor blocking agents esp. cardioselective blocking agents, also intermediates
Okmanov et al. Crystal structures of (S)-3-{1-[(4-chlorophenyl) sulfonyl] piperidin-2-yl} pyridine,(S)-3-[1-(4-methylphenyl) piperidin-2-yl] pyridine,(S)-3-{1-[(4-methoxyphenyl) sulfonyl] piperidin-2-yl} pyridine and (S)-3-{1-[(3, 4-dimethylphenyl) sulfonyl] piperidin-2-yl} pyridine

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee